PRECIGEN, INC. Payments to Acquire Interest in Subsidiaries and Affiliates
PRECIGEN, INC. (PGEN) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2022-03-01
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-12-31 was $0.00.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2021 was $0.00.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2019 was $3.71M, a 77.61% decline from fiscal 2018.
- PRECIGEN, INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2018 was $16.58M, a 48.20% increase from fiscal 2017.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 3 month | Payments to Acquire Interest in Subsidiaries and Affiliates 6 month | Payments to Acquire Interest in Subsidiaries and Affiliates 9 month | Payments to Acquire Interest in Subsidiaries and Affiliates 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $1.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $1.34M derived: sum of 3 quarters · filed 2022-03-01 | $3.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.34M derived: sum of 2 quarters · filed 2022-03-01 | $3.34M derived: sum of 3 quarters · filed 2022-03-01 | $3.71M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.34M derived: sum of 2 quarters · filed 2020-11-09 | $3.71M 10-Q · filed 2020-11-09 | $6.16M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.37M 10-Q · filed 2020-08-10 | $4.81M derived: sum of 3 quarters · filed 2021-03-01 | $10.44M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $370.00K 10-Q · filed 2020-05-11 | $2.81M derived: sum of 2 quarters · filed 2021-03-01 | $8.44M derived: sum of 3 quarters · filed 2021-03-01 | $11.44M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $8.07M derived: sum of 2 quarters · filed 2021-03-01 | $11.07M derived: sum of 3 quarters · filed 2021-03-01 | $16.58M 10-K · filed 2021-03-01 |
| 2018-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $8.63M derived: sum of 2 quarters · filed 2019-11-12 | $14.14M 10-Q · filed 2019-11-12 | $14.69M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.51M 10-Q · filed 2019-08-09 | $9.06M derived: sum of 3 quarters · filed 2020-03-02 | $15.12M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $5.51M 10-Q · filed 2019-05-09 | $6.06M derived: sum of 2 quarters · filed 2020-03-02 | $12.12M derived: sum of 3 quarters · filed 2020-03-02 | $12.12M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.61M derived: sum of 2 quarters · filed 2020-03-02 | $6.61M derived: sum of 3 quarters · filed 2020-03-02 | $11.19M 10-K · filed 2020-03-02 |
| 2017-09-30 | $6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $6.06M derived: sum of 2 quarters · filed 2018-11-08 | $10.64M 10-Q · filed 2018-11-08 | $12.77M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $4.58M 10-Q · filed 2018-08-13 | $6.71M derived: sum of 3 quarters · filed 2019-03-01 | $11.07M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $4.58M 10-Q/A · filed 2018-08-13 | $6.71M derived: sum of 2 quarters · filed 2019-03-01 | $11.07M derived: sum of 3 quarters · filed 2019-03-01 | $13.40M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $6.49M derived: sum of 2 quarters · filed 2019-03-01 | $8.82M derived: sum of 3 quarters · filed 2019-03-01 | $11.54M 10-K · filed 2019-03-01 |
| 2016-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.69M derived: sum of 2 quarters · filed 2017-11-09 | $9.41M 10-Q · filed 2017-11-09 | $18.16M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $5.05M 10-Q · filed 2017-08-09 | $13.80M derived: sum of 3 quarters · filed 2018-03-01 | $15.16M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $2.72M 10-Q · filed 2017-05-10 | $11.46M derived: sum of 2 quarters · filed 2018-03-01 | $12.83M derived: sum of 3 quarters · filed 2018-03-01 | $14.67M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $10.11M derived: sum of 2 quarters · filed 2018-03-01 | $11.95M derived: sum of 3 quarters · filed 2018-03-01 | $13.44M 10-K · filed 2018-03-01 |
| 2015-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.21M derived: sum of 2 quarters · filed 2016-11-09 | $4.70M 10-Q · filed 2016-11-09 | $5.47M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.33M 10-Q · filed 2016-08-09 | $4.10M derived: sum of 3 quarters · filed 2017-03-01 | $4.71M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.49M 10-Q · filed 2016-05-10 | $2.26M derived: sum of 2 quarters · filed 2017-03-01 | $2.87M derived: sum of 3 quarters · filed 2017-03-01 | $2.87M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $770.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.38M derived: sum of 2 quarters · filed 2017-03-01 | $1.38M derived: sum of 3 quarters · filed 2017-03-01 | $2.88M 10-K · filed 2017-03-01 |
| 2014-09-30 | $605.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $605.00K derived: sum of 2 quarters · filed 2015-11-09 | $2.10M 10-Q · filed 2015-11-09 | $7.11M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.50M 10-Q · filed 2015-08-10 | $6.50M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $1.50M 10-Q · filed 2015-05-11 | $6.50M derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.00M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | |||
| 2012-12-31 | $6.00M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |